This information was published on 2025-12-25T06:13:29 for IP Right Filed Published.
| Field | Value |
| (210) | 2614963 (IR 1893122) |
| (220) |
05 Nov 2025
|
| (300) |
US, 05 Nov 2025, 99480274
|
| (500) |
The mark consists of the wording "XOLREMDI" in blue and purple with a design to the left of "XOLREMDI" consisting of circles in orange, blue and purple forming three curved lines.
The color(s) blue, orange and purple is/are claimed as a feature of the mark. The mark consists of the wording "XOLREMDI" in blue and purple with a design to the left of "XOLREMDI" consisting of circles in orange, blue and purple forming three curved lines. |
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of WHIM syndrome; pharmaceutical preparations for the treatment of immunodeficiencies; pharmaceutical preparations for the treatment of neutropenia. |
| (540) |
|
| (550) | Figurative |
| (730) |
X4 Pharmaceuticals, Inc.
|
Find out more about publications on the About page.